Patents Assigned to BML Pharmaceuticals, Inc.
  • Method of treating mucositis
    Patent number: 7566740
    Abstract: A method of treating mucositis in immunocompromised patients is disclosed which is based on contacting the affected area with an amount of composition which comprises triclosan and a cationic antibacterial agent in amounts which are effective to alleviate the symptoms of mucositis.
    Type: Grant
    Filed: December 12, 2002
    Date of Patent: July 28, 2009
    Assignee: BML Pharmaceuticals, Inc.
    Inventor: Barry Libin
  • Antimicrobial solutions
    Patent number: 6537526
    Abstract: A water based composition having triclosan in an amount of 0.01 to 3% by weight in combination with from 5-35% by weight of a non-toxic polyhydric alcohol and from 0.5-5% by weight of a poloxamer.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: March 25, 2003
    Assignee: BML Pharmaceuticals, Inc.
    Inventor: Barry M. Libin